Survival
The rates of recurrences (23.7% versus 23.6%, p = 0.949) and deaths of disease (13.9% versus 9.1%, p = 0.076) did not differ between groups. Likewise, median disease-free (26 versus 28 months, p = 0.427) and disease-specific survival (25 versus 28 months, p = 0.183) was comparable for training and non-training cases (table 3).
Figure 1 and 2 show the Kaplan-Meier curves for 5-year disease-free and disease-specific survival for training and non-training cases. The estimated 5-year disease-free survival is 59.1% (95%-CI: 48.5 – 68.3%) for non-training cases and 65.8% (95%-CI 58.0 – 72.5%) for training cases (p = 0.607). The estimated 5-year disease-specific survival is 81.7% (95%-CI 74.0 – 87.2%) for non-training and 75.5% (95%-CI 68.2 – 81.4%) for training cases (p = 0.276).